Requirement of the Yersinia pseudotuberculosis effectors YopH and YopE in colonization and persistence in intestinal and lymph tissues
- PMID: 12874339
- PMCID: PMC166012
- DOI: 10.1128/IAI.71.8.4595-4607.2003
Requirement of the Yersinia pseudotuberculosis effectors YopH and YopE in colonization and persistence in intestinal and lymph tissues
Abstract
The gram-negative enteric pathogen Yersinia pseudotuberculosis employs a type III secretion system and effector Yop proteins that are required for virulence. Mutations in the type III secretion-translocation apparatus have been shown to cause defects in colonization of the murine cecum, suggesting roles for one or more effector Yops in the intestinal tract. To investigate this possibility, isogenic yop mutant strains were tested for their ability to colonize and persist in intestinal and associated lymph tissues of the mouse following orogastric inoculation. In single-strain infections, a yopHEMOJ mutant strain was unable to colonize, replicate, or persist in intestinal and lymph tissues. A yopH mutant strain specifically fails to colonize the mesenteric lymph nodes, but yopE and yopO mutant strains showed only minor defects in persistence in intestinal and lymph tissues. While no single Yop was found to be essential for colonization or persistence in intestinal tissues in single-strain infections, the absence of both YopH and YopE together almost eliminated colonization of all tissues, indicating either that these two Yops have some redundant functions or that Y. pseudotuberculosis employs multiple strategies for colonization. In competition infections with wild-type Y. pseudotuberculosis, the presence of wild-type bacteria severely hindered the ability of the yopH, yopE, and yopO mutants to persist in many tissues, suggesting that the wild-type bacteria either fills colonization niches or elicits host responses that the yop mutants are unable to withstand.
Figures






Similar articles
-
The proinflammatory response induced by wild-type Yersinia pseudotuberculosis infection inhibits survival of yop mutants in the gastrointestinal tract and Peyer's patches.Infect Immun. 2006 Mar;74(3):1516-27. doi: 10.1128/IAI.74.3.1516-1527.2006. Infect Immun. 2006. PMID: 16495522 Free PMC article.
-
Yersinia pseudotuberculosis efficiently escapes polymorphonuclear neutrophils during early infection.Infect Immun. 2014 Mar;82(3):1181-91. doi: 10.1128/IAI.01634-13. Epub 2013 Dec 30. Infect Immun. 2014. PMID: 24379291 Free PMC article.
-
Proinflammatory signalling stimulated by the type III translocation factor YopB is counteracted by multiple effectors in epithelial cells infected with Yersinia pseudotuberculosis.Mol Microbiol. 2003 Mar;47(5):1305-15. doi: 10.1046/j.1365-2958.2003.03350.x. Mol Microbiol. 2003. PMID: 12603736
-
The Yersinia Yop virulon: a bacterial system for subverting eukaryotic cells.Mol Microbiol. 1997 Mar;23(5):861-7. doi: 10.1046/j.1365-2958.1997.2731623.x. Mol Microbiol. 1997. PMID: 9076724 Review.
-
The Yersinia Yop virulon, a bacterial system to subvert cells of the primary host defense.Folia Microbiol (Praha). 1998;43(3):253-61. doi: 10.1007/BF02818610. Folia Microbiol (Praha). 1998. PMID: 9717252 Review.
Cited by
-
The locus of enterocyte effacement-encoded effector proteins all promote enterohemorrhagic Escherichia coli pathogenicity in infant rabbits.Infect Immun. 2005 Mar;73(3):1466-74. doi: 10.1128/IAI.73.3.1466-1474.2005. Infect Immun. 2005. PMID: 15731044 Free PMC article.
-
Research Progress on Small Molecular Inhibitors of the Type 3 Secretion System.Molecules. 2022 Nov 30;27(23):8348. doi: 10.3390/molecules27238348. Molecules. 2022. PMID: 36500441 Free PMC article. Review.
-
Unraveling neutrophil- Yersinia interactions during tissue infection.F1000Res. 2019 Jul 11;8:F1000 Faculty Rev-1046. doi: 10.12688/f1000research.18940.1. eCollection 2019. F1000Res. 2019. PMID: 31327994 Free PMC article. Review.
-
Innate immune recognition of Yersinia pseudotuberculosis type III secretion.PLoS Pathog. 2009 Dec;5(12):e1000686. doi: 10.1371/journal.ppat.1000686. Epub 2009 Dec 4. PLoS Pathog. 2009. PMID: 19997504 Free PMC article.
-
A horse and a zebra: an atypical clinical picture including Guillain-Barré syndrome, recurrent fever and mesenteric lymphadenopathy caused by two concomitant infections.Infection. 2020 Jun;48(3):471-475. doi: 10.1007/s15010-020-01397-5. Epub 2020 Mar 3. Infection. 2020. PMID: 32128685 Free PMC article.
References
-
- Andersson, K., N. Carballeira, K. E. Magnusson, C. Persson, O. Stendahl, H. Wolf-Watz, and M. Fallman. 1996. YopH of Yersinia pseudotuberculosis interrupts early phosphotyrosine signalling associated with phagocytosis. Mol. Microbiol. 20:1057-1069. - PubMed
-
- Autenrieth, I. B., and R. Firsching. 1996. Penetration of M cells and destruction of Peyer's patches by Yersinia enterocolitica: an ultrastructural and histological study. J. Med. Microbiol. 44:285-294. - PubMed
-
- Barz, C., T. N. Abahji, K. Trulzsch, and J. Heesemann. 2000. The Yersinia Ser/Thr protein kinase YpkA/YopO directly interacts with the small GTPases RhoA and Rac-1. FEBS Lett. 482:139-143. - PubMed
-
- Black, D. S., and J. B. Bliska. 2000. The RhoGAP activity of the Yersinia pseudotuberculosis cytotoxin YopE is required for antiphagocytic function and virulence. Mol. Microbiol. 37:515-527. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources